Revolution Medicines, Inc. (RVMD) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US76155X1000
Revolution Medicines, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 0.00 USD |
| Operating income | -1.18 bn USD |
| EBIT | -1.20 bn USD |
| Net income | -1.13 bn USD |
| Diluted EPS – continuing operations | -5.95 USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Revolution Medicines, Inc.
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
More stocks
- Japan Post Holdings Co Ltd (6178.T)
- Sumitomo Electric Industries Ltd (5802.T)
- Wuliangye Yibin Co Ltd (000858.SZ)
- Idexx Laboratories (IDXX)
- TWILIO INC (TWLO)
- Bank Central Asia Tbk (BBCA.JK)
- Dai-ichi Life Holdings Inc (8750.T)
- Power Corporation of Canada (POW.TO)
- Mercedes-Benz Group (MBG.DE)
- ILLUMINA, INC. (ILMN)
- DSV A/S (DSV.CO)
- MSCI (MSCI)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.